11:19 AM EDT, 06/03/2025 (MT Newswires) -- McKesson (MCK) said Tuesday it finalized the acquisition of a 70% controlling interest in Core Ventures for approximately $2.49 billion.

The Florida Cancer Specialists & Research Institute, which established Core Ventures, retained a 30% interest in the business and administrative services firm.

Shares were down 2.1% in recent trading.

Price: 706.77, Change: -15.07, Percent Change: -2.09